Zhun Hong Wong Nicky, Wei Ting Yap Dominic, Lei Ng Sherryl, Yu Ning Ng Junie, James Juanita Jaslin, Wei Chieh Kow Alfred
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.
Front Surg. 2024 Jun 11;11:1369169. doi: 10.3389/fsurg.2024.1369169. eCollection 2024.
Advancements in surgical techniques have improved outcomes in patients undergoing pancreatic surgery. To date there have been no meta-analyses comparing robotic and laparoscopic approaches for distal pancreatectomies (DP) in patients with pancreatic adenocarcinoma (PDAC). This systematic review and network meta-analysis aims to explore the oncological outcomes of laparoscopic distal pancreatectomy (LDP), robotic distal pancreatectomy (RDP) and open distal pancreatectomy (ODP).
A systematic search was conducted for studies reporting laparoscopic, robotic or open surgery for DP. Frequentist network meta-analysis of oncological outcomes (overall survival, resection margins, tumor recurrence, examined lymph nodes, administration of adjuvant therapy) were performed.
Fifteen studies totalling 9,301 patients were included in the network meta-analysis. 1,946, 605 and 6,750 patients underwent LDP, RDP and ODP respectively. LDP (HR: 0.761, 95% CI: 0.642-0.901, = 0.002) and RDP (HR: 0.757, 95% CI: 0.617-0.928, = 0.008) were associated with overall survival (OS) benefit when compared to ODP. LDP (HR: 1.00, 95% CI: 0.793-1.27, = 0.968) was not associated with OS benefit when compared to RDP. There were no significant differences between LDP, RDP and ODP for resection margins, tumor recurrence, examined lymph nodes and administration of adjuvant therapy.
This study highlights the longer OS in both LDP and RDP when compared to ODP for patients with PDAC.
https://www.crd.york.ac.uk/, PROSPERO (CRD42022336417).
手术技术的进步改善了接受胰腺手术患者的治疗效果。迄今为止,尚无荟萃分析比较机器人手术和腹腔镜手术治疗胰腺腺癌(PDAC)患者远端胰腺切除术(DP)的效果。本系统评价和网状荟萃分析旨在探讨腹腔镜远端胰腺切除术(LDP)、机器人远端胰腺切除术(RDP)和开放远端胰腺切除术(ODP)的肿瘤学结局。
对报告DP的腹腔镜、机器人或开放手术的研究进行系统检索。对肿瘤学结局(总生存期、切缘、肿瘤复发、检查的淋巴结、辅助治疗的应用)进行频率学派网状荟萃分析。
15项研究共9301例患者纳入网状荟萃分析。分别有1946例、605例和6750例患者接受了LDP、RDP和ODP。与ODP相比,LDP(风险比:0.761,95%置信区间:0.642 - 0.901,P = 0.002)和RDP(风险比:0.757,95%置信区间:0.617 - 0.928,P = 0.008)与总生存期(OS)获益相关。与RDP相比,LDP(风险比:1.00,95%置信区间:0.793 - 1.27,P = 0.968)与OS获益无关。LDP、RDP和ODP在切缘、肿瘤复发、检查的淋巴结和辅助治疗的应用方面无显著差异。
本研究强调,对于PDAC患者,与ODP相比,LDP和RDP的OS更长。